Impact of COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: a possible role of the association to anti-CD20 antibody? A multicentre SEIFEM study

被引：0
|
作者：
Autore, Francesco
Visentin, Andrea
Deodato, Marina
Vitale, Candida
Galli, Eugenio
Fresa, Alberto
Fazzi, Rita
Sanna, Alessandro
Olivieri, Jacopo
Scortechini, Ilaria
del Principe, Maria Ilaria
Sportoletti, Paolo
Schiattone, Luana
Maschio, Nilla
Facchinelli, Davide
Coscia, Marta
Tedeschi, Alessandra
Trentin, Livio
Innocenti, Idanna
Candoni, Anna
Busca, Alessandro
Pagano, Livio
Laurenti, Luca
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1552495
引用
收藏
页码：S27 / S28
页数：2
相关论文
共 50 条
  • [1] Impact of COVID-19 in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Possible Role of the Association to Anti-CD20 Antibody? a Multicentre Seifem Study
    Autore, Francesco
    Visentin, Andrea
    Deodato, Marina
    Vitale, Candida
    Galli, Eugenio
    Fresa, Alberto
    Fazzi, Rita
    Sanna, Alessandro
    Olivieri, Jacopo
    Scortechini, Ilaria
    Del Principe, Maria Ilaria
    Sportoletti, Paolo
    Schiattone, Luana
    Maschio, Nilla
    Facchinelli, Davide
    Coscia, Marta
    Tedeschi, Alessandra
    Trentin, Livio
    Innocenti, Idanna
    Candoni, Anna
    Busca, Alessandro
    Pagano, Livio
    Laurenti, Luca
    BLOOD, 2023, 142
  • [2] COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?
    Autore, Francesco
    Visentin, Andrea
    Deodato, Marina
    Vitale, Candida
    Galli, Eugenio
    Fresa, Alberto
    Fazzi, Rita
    Sanna, Alessandro
    Olivieri, Jacopo
    Scortechini, Ilaria
    Principe, Maria Ilaria Del
    Sportoletti, Paolo
    Innocenti, Idanna
    Coscia, Marta
    Tedeschi, Alessandra
    Trentin, Livio
    Candoni, Anna
    Busca, Alessandro
    Pagano, Livio
    Laurenti, Luca
    BLOOD ADVANCES, 2025, 9 (01) : 162 - 165
  • [3] Omission of Anti-CD20 Antibody in Chronic Lymphocytic Leukemia during COVID-19 Pandemic: Twelve Month Course of Venetoclax Is a Safe and Effective Alternative Regimen
    Shahab, Aarib M.
    Yunus, Saadia
    BLOOD, 2023, 142
  • [4] Impact of Anti-CD20 Antibodies on the Incidence of Secondary Cancers in Patients Treated for Chronic Lymphocytic Leukemia
    Guidez, Stephanie
    Demarquette, Helene
    Nudel, Morgane
    Le Grand, Charline
    Boyle, Eileen
    Herbaux, Charles
    Facon, Thierry
    Cazin, Bruno
    Morschhauser, Franck
    BLOOD, 2015, 126 (23)
  • [5] IMPACT OF ANTI-CD20 ANTIBODIES ON THE INCIDENCE OF SECONDARY CANCERS IN PATIENTS TREATED FOR CHRONIC LYMPHOCYTIC LEUKEMIA
    Guidez, S.
    Demarquette, H.
    Nudel, M.
    Le Grand, C.
    Herbaux, C.
    Facon, T.
    Cazin, B.
    Morschhauser, F.
    HAEMATOLOGICA, 2016, 101 : 443 - 444
  • [6] Chronic Obstructive Pulmonary Disease and Previous Infections Have Impact on Infectious Complications in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Multicentre Seifem Study
    Autore, Francesco
    Visentin, Andrea
    Deodato, Marina
    Vitale, Candida
    Galli, Eugenio
    Fresa, Alberto
    Fazzi, Rita
    Sanna, Alessandro
    Olivieri, Jacopo
    Scortechini, Ilaria
    Del Principe, Maria Ilaria
    Sportoletti, Paolo
    Schiattone, Luana
    Maschio, Nilla
    Facchinelli, Davide
    Coscia, Marta
    Tedeschi, Alessandra
    Trentin, Livio
    Innocenti, Idanna
    Candoni, Anna
    Busca, Alessandro
    Pagano, Livio
    Laurenti, Luca
    BLOOD, 2023, 142
  • [7] Chronic obstructive pulmonary disease and previous infections have impact on infectious complications in patients with chronic lymphocytic leukemia treated with venetoclax: a multicentre SEIFEM study.
    Autore, Francesco
    Visentin, Andrea
    Deodato, Marina
    Vitale, Candida
    Galli, Eugenio
    Fresa, Alberto
    Fazzi, Rita
    Sanna, Alessandro
    Olivieri, Jacopo
    Scortechini, Ilaria
    del Principe, Maria Ilaria
    Sportoletti, Paolo
    Schiattone, Luana
    Maschio, Nilla
    Facchinelli, Davide
    Coscia, Marta
    Tedeschi, Alessandra
    Trentin, Livio
    Innocenti, Idanna
    Candoni, Anna
    Busca, Alessandro
    Pagano, Livio
    Laurenti, Luca
    LEUKEMIA & LYMPHOMA, 2023, 64 : S60 - S61
  • [8] Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
    Chuda, Ravindra R.
    Vishnu, Prakash
    Aboulafia, David
    CURRENT DRUG THERAPY, 2012, 7 (04) : 281 - 289
  • [9] Treatment of chronic lymphocytic leukemia (CLL)with the anti-CD20 antibody rituximab.
    Emmerich, B
    Huhn, D
    Peschel, C
    Wilhelm, M
    von Schilling, C
    Bentz, M
    Hallek, M
    Knauf, B
    Kuse, R
    Ho, AD
    BLOOD, 1999, 94 (10) : 309B - 309B
  • [10] Risk factors for hypogammaglobulinemia in chronic lymphocytic leukemia patients treated with anti-CD20 monoclonal antibody-based therapies
    Caitlin M. McNulty
    Emasenyie A. Isikwei
    Pragya Shrestha
    Melissa R. Snyder
    Brian F. Kabat
    Kari G. Rabe
    Susan L. Slager
    Sameer A. Parikh
    Avni Y. Joshi
    Journal of Hematopathology, 2020, 13 : 221 - 229
12345